Martijn Kleijwegt
Managing Partner · EQT Life Sciences
Martijn Kleijwegt, Managing Partner at EQT Life Sciences (formerly Life Sciences Partners), invests in European biotech and pharma companies across stages from Series A to Series F, focusing on innovative drug development for both common and rare diseases[3][9]. His notable portfolio includes Vico Therapeutics (Series A), AM-Pharma (Series F), Eloxx Pharmaceuticals (Series C), and Orphazyme[3]. K…
- Stages: Pre-Seed, Seed, Series A
- Focus: Biotech
- Location: Amsterdam, Noord-Holland, The Netherlands
LinkedIn
Browse all investors · Browse founders
